Starlight Cardiovascular announced that the first baby in the world was treated with its Lifeline(TM) Ductus Arteriosus Stent System at Cincinnati Children's Hospital in January. The device is ...

Starlight Cardiovascular announced today that the first baby in the world received treatment with its Lifeline pediatric ...

Medical device and healthcare company Abbott arranged to have their canine and kid patients treated for patent ductus arteriosus meet in Los Angeles Kelli Bender is the Pets Editor at PEOPLE. She has ...

Credit: Getty Images. Evidence suggests that patent ductus arteriosus comprises anywhere from 5% to 10% of all congenital heart disease. Although the majority of congenital heart diseases (CHD) are ...

Are you searching for medications to treat 'Patent Ductus Arteriosus'? Welcome to this page which serves as an archive for medications that are relevant to the treatment of Patent Ductus Arteriosus.

In contrast with the full term newborn, preterm infants frequently fail to close their ductus arteriosus after birth. Persistent ductus patency alters mesenteric blood flow, impairs pulmonary ...

The cyclooxygenase inhibitor ibuprofen may be used to treat patent ductus arteriosus (PDA) in preterm infants. Whether selective early treatment of large PDAs with ibuprofen would improve short-term ...

SHOULD closure of a patent ductus arteriosus with reversal of flow be attempted? If so, how can the high surgical mortality hitherto reported 1–3 be reduced? An attempt is made to answer these ...

Patent Ductus arteriosus is the second commonest congenital birth defect of the heart and can cause heart failure; however majority of these defect close spontaneously after birth. Patent Ductus ...

This article presents common misconceptions about the physiologic significance of early ductal shunting and reviews the evidence regarding the preferential use of echocardiography rather than reliance ...

Patent ductus arteriosus (PDA) is a congenital cardiac defect that occurs when the ductus arteriosus fails to close. The result is a persistent communication between the aorta and pulmonary artery, ...